CJC-1295 DAC – Research Overview
Introduction
CJC-1295 DAC peptide is a synthetic compound developed to support long-acting research models related to growth hormone–releasing hormone (GHRH) signaling. Unlike short-acting GHRH analogs, this peptide incorporates a Drug Affinity Complex (DAC), which enables reversible binding to serum albumin.
As a result, the compound maintains biological availability for an extended period under controlled laboratory conditions. Therefore, researchers often select this DAC-modified GHRH peptide when experimental designs require sustained hormonal signaling rather than short, transient exposure.
What Makes CJC-1295 DAC Distinct
DAC-Modified GHRH Structure
CJC-1295 with DAC originates from a modified GHRH sequence. The DAC component limits enzymatic degradation and slows molecular clearance in experimental systems.
Consequently, laboratories can observe extended signaling patterns while maintaining stable experimental parameters. Moreover, this characteristic differentiates the peptide from non-DAC GHRH analogs commonly applied in short-term research assays.
Research Applications and Scientific Context
Endocrine and Metabolic Research
Researchers frequently apply this long-acting GHRH analog in studies focused on:
-
Growth hormone release dynamics
-
Hypothalamic–pituitary signaling pathways
-
Hormonal feedback mechanisms
-
Metabolic regulation models
In addition, extended activity allows researchers to reduce dosing frequency within experimental designs. As a result, observation becomes more consistent and data comparison across time-based studies becomes more reliable.
Chemical and Physical Characteristics
From a laboratory handling perspective, CJC-1295 DAC peptide typically demonstrates the following characteristics:
-
Synthetic peptide composition
-
DAC-enhanced molecular stability
-
Lyophilized solid form
-
Reliable solubility in aqueous laboratory solutions
Moreover, appropriate storage conditions and controlled reconstitution procedures support reproducibility across repeated experimental workflows.
Handling and Storage Guidelines
To preserve peptide integrity, laboratories typically store this compound under low-temperature and dry conditions. Researchers then prepare solutions using sterile laboratory solvents immediately prior to experimental use.
For this reason, adherence to established peptide handling protocols plays a critical role in maintaining consistent analytical outcomes.
Research-Only Status
CJC-1295 DAC peptide is supplied strictly for scientific investigation. It does not carry approval for human or veterinary use and holds no recognized clinical or therapeutic indication.
At the same time, all interpretations of experimental results should remain confined to laboratory, analytical, or preclinical research settings.
